Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.
| Autor: | Fowler, III, Alpha A.1 afowler@mcvh-vcu.edu, Syed, Aamer A.1 asyed@mcvh-vcu.edu, Knowlson, Shelley2 sknowlson@vcu.edu, Sculthorpe, Robin3 rsculthorpe@mcvh-vcu.edu, Farthing, Don4 defarthi@vcu.edu, DeWilde, Christine1 dewildect@vcu.edu, Farthing, Christine A.4 cafarthing@vcu.edu, Larus, Terri L.4 larustl@vcu.edu, Martin, Erika5 ejmartin@vcu.edu, Brophy, Donald F.5 dbrophy@vcu.edu, Gupta, Seema6 sgupta@hdlabinc.com, Fisher, Bernard J.1 bjfisher@vcu.edu, Natarajan, Ramesh1 rnataraj@vcu.edu |
|---|---|
| Zdroj: | Journal of Translational Medicine. 2014, Vol. 12 Issue 1, p1-24. 24p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|